A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death
- PMID: 18457903
- DOI: 10.1016/j.neurobiolaging.2008.03.015
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death
Abstract
Lewy bodies in Parkinson disease could be innocent bystanders or active agents responsible for neuronal death. Eighteen elderly patients with a Parkinson syndrome were studied prospectively and selected postmortem on the presence of Lewy bodies (14 cases with Parkinson disease, four with dementia with Lewy bodies). Information on disease duration was available in 17 cases. While akinesia and rigidity were linked with the neuronal loss, the percentages of Lewy body bearing neurons and of alpha-synuclein immunoreactive neurons in the substantia nigra were not correlated with the symptoms or the disease duration, and appeared stable, involving 3.6% of the neurons on average. Such stability indicated that, during the whole course of the disease, the destruction of the Lewy bodies was equal to their production. In the model that is proposed here, the Lewy bodies are eliminated when the neurons that bear them die. With the hypothesis that neuronal death is directly related to Lewy bodies, it is possible to estimate their life span, which was calculated to be 6.2 months (15.9 months for any type of alpha-synuclein inclusion).
Similar articles
-
Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.Arch Neurol. 2006 Apr;63(4):584-8. doi: 10.1001/archneur.63.4.584. Arch Neurol. 2006. PMID: 16606773
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.Neurosci Lett. 2005 May 20-27;380(1-2):161-5. doi: 10.1016/j.neulet.2005.01.056. Epub 2005 Feb 3. Neurosci Lett. 2005. PMID: 15854770
-
[Update on the pathophysiology of Parkinson' disease].Bull Acad Natl Med. 2010 Oct;194(7):1287-303; discussion 1303-4. Bull Acad Natl Med. 2010. PMID: 22043625 Review. French.
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
Cited by
-
The significance of neuronal lateralisation in Parkinson's disease.J Neural Transm (Vienna). 2012 Aug;119(8):953-62. doi: 10.1007/s00702-012-0775-1. Epub 2012 Feb 26. J Neural Transm (Vienna). 2012. PMID: 22367437 Review.
-
Criterion for Assessing Accumulated Neurotoxicity of Alpha-Synuclein Oligomers in Parkinson's Disease.Int J Numer Method Biomed Eng. 2025 Apr;41(4):e70027. doi: 10.1002/cnm.70027. Int J Numer Method Biomed Eng. 2025. PMID: 40293716 Free PMC article.
-
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Nat Rev Neurosci. 2022 Feb;23(2):115-128. doi: 10.1038/s41583-021-00542-9. Epub 2021 Dec 14. Nat Rev Neurosci. 2022. PMID: 34907352 Review.
-
Is Braak staging valid for all types of Parkinson's disease?J Neural Transm (Vienna). 2019 Apr;126(4):423-431. doi: 10.1007/s00702-018-1898-9. Epub 2018 Jun 25. J Neural Transm (Vienna). 2019. PMID: 29943229 Review.
-
Functionally different α-synuclein inclusions yield insight into Parkinson's disease pathology.Sci Rep. 2016 Mar 17;6:23116. doi: 10.1038/srep23116. Sci Rep. 2016. PMID: 26984067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources